The 10-second takeaway
For the quarter ended Nov. 30 (Q4), Xyratex beat expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted significantly and GAAP earnings per share shrank to a loss.
Margins dropped across the board.
Xyratex reported revenue of $265.4 million. The four analysts polled by S&P Capital IQ expected net sales of $255.2 million on the same basis. GAAP reported sales were 32% lower than the prior-year quarter's $387.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.24. The four earnings estimates compiled by S&P Capital IQ anticipated -$0.32 per share. GAAP EPS were -$0.29 for Q4 versus $0.65 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 14.5%, 320 basis points worse than the prior-year quarter. Operating margin was -2.3%, 900 basis points worse than the prior-year quarter. Net margin was -3.0%, 780 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $207.2 million. On the bottom line, the average EPS estimate is -$0.20.
Next year's average estimate for revenue is $916.0 million. The average EPS estimate is -$0.16.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 260 members out of 279 rating the stock outperform, and 19 members rating it underperform. Among 74 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 68 give Xyratex a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Xyratex is outperform, with an average price target of $8.67.
Is Xyratex the best tech stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Xyratex to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.